Hamilton, Ontario, September 16, 2011 - Affinity Biologicals, Inc. a Canadian medical device manufacturer, will introduce their newly CE-Marked line of IVD coagulation plasma products to the European market at MEDICA 2011 in Düsseldorf, Germany, November 16-19. At the annual fair, Affinity will feature its recently approved line of in vitro diagnostic (IVD) products: VisuCon™-F Frozen Normal and Abnormal Coagulation Control Plasmas.
“Now that we have gained regulatory approvals for these products in Europe, we feel the next most important step is to get them in front of potential customers and distributors. Exhibiting at MEDICA, which we know to be the world's largest yearly medical trade show, will definitely do this for us,” says Greg Fullerton, marketing manager for Affinity Biologicals, Inc.
Affinity Biologicals, Inc. is a primary manufacturer of products used worldwide in thrombosis and haemostasis research and medical diagnostics. Products include an extensive line of antibodies, conjugates, antibody pairs for immunoassay of human and animal analytes, the VisuLize™ line of complete ELISA kits, and a full line of human plasma products including affinity-depleted factor-deficient plasmas (Factors II through XIII, PC, PS, ATIII), VisuCal ™Calibrator Plasmas and VisuCon™ Control Plasmas. Affinity services include protein purification, antibody production, assay development, custom manufacturing, custom lyophilisation and proficiency testing materials.
Affinity's quality system is registered to ISO 13485(2003) and is USFDA QSR compliant and a registered medical device manufacturer with the US FDA, the Canadian Therapeutic Products Directorate (TPD) and the European Regulatory authorities (CE Mark).
We welcome the media, potential distributors and clients, as well as other visitors to the Affinity Biologicals, Inc. booth: 14 in the Ontario Pavilion in Hall #3.
Contact: Mr. Greg Fullerton, Manager, Marketing & Sales firstname.lastname@example.org [1+ 905-304-9896]
For more information regarding Affinity Biologicals, Inc. and MEDICA please visit www.affinitybiologicals.com or www.medica.de